Entries by

Anpac Bio Completes Over 200,000 Biophysics Based Cancer Detection Tests, With Data Covering Close to 60 Types of Cancer

Anpac Bio Completes Over 200,000 Biophysics Based Cancer Detection Tests, With Data Covering Close to 60 Types of Cancer San Jose, CA, October 26, 2020 – Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and […]

AnPac Bio to Receive Up To USD $8 Million Dollar Grants and Award for R&D, Product Commercialization, and Milestone Achievements

FOR IMMEDIATE RELEASE AnPac Bio to Receive Up To USD $8 Million Dollar Grants and Award for R&D, Product Commercialization, and Milestone Achievements San Jose, CA, October 7, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced […]

AnPac Bio Announces Equity Investment from Keystone Capital Partners for up to $7 Million

FOR IMMEDIATE RELEASE AnPac Bio Announces Equity Investment from Keystone Capital Partners for up to $7 Million San Jose, CA, October 1, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today that the Company has entered […]

AnPac Bio Receives Major Immunology Testing Contract

FOR IMMEDIATE RELEASE AnPac Bio Receives Major Immunology Testing Contract San Jose, CA, September 15, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that the Company entered into […]

AnPac Bio Reports First Six Months of 2020 Financial Results

AnPac Bio Reports First Six Months of 2020 Financial Results SAN JOSE, Calif., September 10, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its financial results for the six months ended June 30, […]

AnPac Bio Announces Positive Results from a Multi-Year Lung Cancer Prognosis and Recurrence Clinical Study

FOR IMMEDIATE RELEASE AnPac Bio Announces Positive Results from a Multi-Year Lung Cancer Prognosis and Recurrence Clinical Study San Jose, CA, September 4, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today positive results from a […]

AnPac Bio Philadelphia Lab Gains U.S. CLIA Lab Certification

FOR IMMEDIATE RELEASE AnPac Bio Philadelphia Lab Gains U.S. CLIA Lab Certification San Jose, CA, August 24, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States announced today that the company received a certificate of registration this month […]

AnPac Bio Opens US Philadelphia Lab Operations

FOR IMMEDIATE RELEASE AnPac Bio Opens US Philadelphia Lab Operations San Jose, CA, August 11, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today that the Company has commenced operations of its new Philadelphia lab, with […]

AnPac Bio Validating Approved COVID-19 Antibody Test

FOR IMMEDIATE RELEASE AnPac Bio Validating Approved COVID-19 Antibody Test San Jose, CA, August 7, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States announced today that the Company has been validating an approved COVID-19 antibody test, which […]

©2019 Anpac Bio-Medical Science Co., Ltd.